Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.555
+0.055 (10.90%)
At close: Mar 9, 2026, 4:00 PM EDT
0.550
-0.005 (-0.95%)
After-hours: Mar 9, 2026, 7:55 PM EDT
Gossamer Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 129 | 205 | 206 | 205 | 854 | 701 | |
| Market Cap Growth | -62.93% | -0.34% | 0.56% | -76.06% | 21.87% | -26.45% | |
| Enterprise Value | 151 | 82 | 93 | 118 | 673 | 329 | |
| Last Close Price | 0.56 | 0.90 | 0.91 | 2.17 | 11.31 | 9.67 | |
| PS Ratio | 2.92 | 1.79 | - | - | - | - | |
| PB Ratio | - | 6.95 | 3.28 | 16.94 | 7.03 | 2.19 | |
| P/TBV Ratio | - | 6.95 | 3.28 | 16.94 | 7.03 | 2.19 | |
| EV/Sales Ratio | 3.43 | 0.71 | - | - | - | - | |
| Debt / Equity Ratio | -2.46 | 6.88 | 3.39 | 18.69 | 1.53 | 0.57 | |
| Net Debt / Equity Ratio | -0.28 | -3.11 | -1.34 | -2.48 | -1.15 | -1.03 | |
| Net Debt / EBITDA Ratio | -0.15 | 1.55 | 0.49 | 0.14 | 0.65 | 1.57 | |
| Net Debt / FCF Ratio | -0.14 | 26.42 | 0.53 | 0.16 | 0.74 | 1.85 | |
| Asset Turnover | 0.16 | 0.37 | - | - | - | - | |
| Quick Ratio | 3.06 | 6.66 | 5.75 | 5.19 | 8.16 | 13.27 | |
| Current Ratio | 3.28 | 6.89 | 5.94 | 5.32 | 8.32 | 13.51 | |
| Return on Equity (ROE) | - | -122.54% | -480.50% | -343.53% | -105.85% | -72.30% | |
| Return on Assets (ROA) | -34.25% | -11.94% | -37.17% | -44.34% | -30.58% | -27.25% | |
| Return on Capital Employed (ROCE) | -104.50% | -22.20% | -66.70% | -97.90% | -71.10% | -42.10% | |
| Earnings Yield | -121.50% | -27.58% | -87.42% | -112.15% | -27.39% | -34.71% | |
| FCF Yield | -123.33% | -1.69% | -77.38% | -91.64% | -22.29% | -25.37% | |
| Buyback Yield / Dilution | -0.46% | -48.23% | -80.46% | -13.00% | -9.24% | -25.16% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.